Clear Harbor Asset Management, LLC Spectrum Pharmaceuticals Inc Transaction History

Clear Harbor Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$3.38 - $5.14 $33,698 - $51,245	-9,970 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$2.99 - $4.9 $29,810 - $48,853	9,970 New	9,970 $40,000
Q2 2020 Aug 05, 2020	SELL	$2.11 - $3.38 $79,061 - $126,648	-37,470 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$1.83 - $3.45 $50,325 - $94,875	27,500 Added 275.83%	37,470 $87,000
Q4 2019 Jan 29, 2020	BUY	$3.5 - $10.35 $34,895 - $103,189	9,970 New	9,970 $36,000
Q1 2019 Apr 19, 2019	SELL	$9.08 - $11.84 $91,181 - $118,897	-10,042 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$8.75 - $14.07 $87,867 - $141,290	10,042	10,042 $141,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.